PHARMACOKINETICS OF AZATHIOPRINE (AZA) AND 6-MERCAPTOPURINE (6-MP) AFTER ORAL-ADMINISTRATION OF AZA

被引：0
|
作者：
SALEMANS, J [1 ]
HOITSMA, A [1 ]
DEABREU, R [1 ]
DEVOS, D [1 ]
机构：
[1] CATHOLIC UNIV NIJMEGEN,DIV NEPHROL,NIJMEGEN,NETHERLANDS
来源：
KIDNEY INTERNATIONAL | 1987年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1047 / 1047
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF 6-MERCAPTOPURINE AFTER ORAL-ADMINISTRATION OF AZATHIOPRINE
    DEVOS, D
    SALEMANS, J
    HOITSMA, AJ
    DEABREU, RA
    KOENE, RAP
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1987, 9 (06) : 336 - 336
  • [2] Hepatotoxicity of 6-mercaptopurine (6-MP) and azathioprine (AZA) in adult IBD patients
    Shaye, Omid A.
    Yadegari, Michael
    Abreu, Maria T.
    Poordad, Fred
    Simon, Karen
    Martin, Paul
    Papadakis, Konstantinos A.
    Ippoliti, Andrew
    Vasiliauskas, Eric
    Tran, Tram T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (11): : 2488 - 2494
  • [3] Treatment of Crohn's disease (CD) with 6-mercaptopurine (6-MP) in patients intolerant to azathioprine (AZA).
    Lemann, M
    Bouhnik, Y
    Corguille, MKL
    Bonnet, J
    Coffin, B
    Marteau, P
    Bitoun, A
    Messing, B
    Jian, R
    Matuchansky, C
    Modigliani, R
    Rambaud, JC
    GASTROENTEROLOGY, 1997, 112 (04) : A1025 - A1025
  • [4] Drug monitoring of azathioprine (AZA) and 6-mercaptopurine (6-MP) among adult patients with inflammatory bowel disease (IBD).
    Hindorf, UN
    Lyrenas, E
    Nilsson, A
    Schmiegelow, K
    GASTROENTEROLOGY, 2001, 120 (05) : A623 - A623
  • [5] Azathioprine/6-mercaptopurine (AZA/6-MP) reduces the risk of intestinal re-operation in Crohn's Disease(CD)
    Papay, Pavol
    Ho, Elien
    Reinisch, Walter
    Miehsler, Wolfgang
    Vogelsang, Harald
    Novacek, Gottfried
    GASTROENTEROLOGY, 2007, 132 (04) : A52 - A52
  • [6] Effect of azathioprine/6-mercaptopurine (AZA/6-MP) on natural history of inflammatory bowel disease (IBD) in a population-based cohort
    Loftus, CG
    Loftus, EV
    Tremaine, WJ
    Harmsen, WS
    Zinsmeister, AR
    Sandborn, WJ
    GASTROENTEROLOGY, 2004, 126 (04) : A474 - A475
  • [7] PHARMACOKINETICS OF 6-THIOURIC ACID AND 6-MERCAPTOPURINE IN RENAL-ALLOGRAFT RECIPIENTS AFTER ORAL-ADMINISTRATION OF AZATHIOPRINE
    CHAN, GLC
    ERDMANN, GR
    GRUBER, SA
    STOCK, P
    CHEN, S
    ASCHER, NL
    CANAFAX, DM
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (03) : 265 - 271
  • [8] Is preoperative azathioprine (AZA), 6-mercaptopurine (6-MP) or corticosteroids (CS) use for elective bowel surgery associated with postoperative infectious complications?
    Aberra, F
    Lewis, JD
    Lichtenstein, GR
    GASTROENTEROLOGY, 2001, 120 (05) : A623 - A623
  • [9] Safety and efficacy of 6-thioguanine (6-TG) in patients with ulcerative and indeterminate colitis intolerant or resistant to azathioprine and/or 6-mercaptopurine (Aza/6-MP)
    Teml, A
    Harrer, M
    Schwab, M
    Dejaco, C
    Mantl, M
    Vogelsang, H
    Reinisch, W
    GASTROENTEROLOGY, 2003, 124 (04) : A524 - A524
  • [10] Correlation between 6-mercaptopurine (6-MP) pharmacokinetic, blood lymphocyte subpopulations and clinical response to azathioprine (AZA) in Crohn's disease (CD).
    Cattan, S
    Lemann, M
    Thullier, F
    Rabian, C
    Ngo, Y
    Bengoufa, D
    Messing, B
    Rambaud, JC
    Modigliani, R
    GASTROENTEROLOGY, 1996, 110 (04) : A880 - A880
12345